Cedar was founded in 2016 by Arel Lidow, Florian Otto, and Kareem Zaki. While the company is growing quickly, nobody has publicly discussed plans for a future IPO. These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Cedar is a fintech company and developer of a healthcare financial engagement platform for hospitals, health systems and medical groups that clarifies and simplifies the financial experience for patients, improving bill resolution and payment outcomes for providers. In 2021, Cedar acquired OODA Health, the makers of a powerful billing platform, for $425 million. Cedar has raised a total of $350 million in venture capital funding, most recently in a $200 million round that included investors Tiger Global Management, Thrive Capital, Concord Health Partners, and Andreessen Horowitz. This latest round raised the company's valuation to $3.2 billion.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/19/2022 | Series D | $255MM | $xx.xx | $3.19B | Andreessen Horowitz, Concord Health Partners, Memorial Hermann Health System, Thrive Capital, Tiger Global Management | |
Price per Share
$xx.xx
Shares Outstanding
1,060,175
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Concord Health Partners, Memorial Hermann Health System, Thrive Capital, Tiger Global Management
|
||||||
06/22/2020 | Series C | $79.8MM | $xx.xx | $814.72MM | Andreessen Horowitz, Jp Morgan | |
Price per Share
$xx.xx
Shares Outstanding
1,335,516
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Jp Morgan
|
||||||
06/25/2018 | Series B | $41.3MM | $xx.xx | $286.28MM | Founders Fund, Kevin Systrom, Kinnevik, Lakestar, Nat Turner, Sound Ventures, Thrive Capital | |
Price per Share
$xx.xx
Shares Outstanding
1,978,507
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Founders Fund, Kevin Systrom, Kinnevik, Lakestar, Nat Turner, Sound Ventures, Thrive Capital
|
||||||
12/06/2017 | Series A-1 | $3MM | $xx.xx | $73.6MM | Founders Fund, Martin Ventures, Sv Angel, Thrive Capital | |
Price per Share
$xx.xx
Shares Outstanding
1,288,214
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Founders Fund, Martin Ventures, Sv Angel, Thrive Capital
|
||||||
12/06/2017 | Series A | $10MM | $xx.xx | $73.6MM | Founders Fund, Martin Ventures, Sv Angel, Thrive Capital | |
Price per Share
$xx.xx
Shares Outstanding
1,533,567
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Founders Fund, Martin Ventures, Sv Angel, Thrive Capital
|